Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Doug Cole is a Managing Partner at Flagship Pioneering, directing investments in BioTech and Pharmaceuticals companies at Series A and Series B stages, with investment amounts typically ranging from $100K to $5.0M. Cole has established expertise in identifying and nurturing innovative companies in the life sciences and healthcare sectors. His investment approach focuses on businesses with transformative potential in healthcare and biotechnology. He is based in Cambridge, Massachusetts.
Previous investments
Repertoire Immune Medicines
190M |2021
25M |2017
Harbinger Health
140M |2023
50M |2021
Vesalius Therapeutics
75M |2022
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.